Invesco S&P SmallCap Health Care ETF (PSCH) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores PSCH 2.7 out of 10 — highest on Value (5.0), lowest on Quality (0.8). It trades at 26.5 times earnings, against its own median of 23.4. Its ten largest holdings are 35% of the fund.
What stands out in PSCH's data
U.S. small-cap health care firms, from biotech to medical equipment.
Earns more on its equity than most small-cap health peers — a sign of real profitability in a volatile sector.
Return on equity of 30.7% sits ahead of most peers, above the category median of 29.4% and its own 27.7% historical median. EBITDA margin runs at 16.2%.
A focused small-cap health care position for a portfolio that already holds broad U.S. equities.
Why did PSCH move this week? It rose 1.3% in the week to October 9, 2026 — Pacira Biosciences and Waystar drove it
PSCH rose 1.3% in the week to October 9, 2026. The holdings that moved it most were Pacira Biosciences (+44.0%), Waystar (+7.5%) and Protagonist Therapeutics (+2.6%); Neogenomics (−11.5%) pushed the other way.
How is PSCH rated? ETF Copilot scores Invesco S&P SmallCap Health Care ETF (PSCH) 2.7 out of 10
As of October 9, 2026, ETF Copilot scores Invesco S&P SmallCap Health Care ETF (PSCH) 2.7 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 2.7 / 10
- Growth: 3.3 / 10
- Value: 5.0 / 10
- Risk: 1.9 / 10
- Quality: 0.8 / 10
- Return: 2.2 / 10
Is PSCH expensive right now? It trades at 26.5 times earnings, against its own median of 23.4
As of October 9, 2026, PSCH is more expensive than 67% of its own last 9 years.
Trailing 12 months, built from PSCH's holdings. How we calculate this →
What's inside PSCH?
What's inside PSCH: Size (Large 0%, Mid 36%, Small 64%); Geography (International 5%, US 95%); Tech 1.8%.
What are PSCH's top holdings? The ten largest are 35% of the fund
Glaukos, Protagonist Therapeutics, TG Therapeutics, Alkermes, Ligand Pharmaceuticals, Teleflex, PTC Therapeutics, Merit Medical Systems, Radnet and Concentra Group Holdings Parent are PSCH's largest holdings, in that order.
Less concentrated than 72% of Health & Biotech ETFs.
Half of PSCH's weight sits in its 18 largest positions, and once those weights are taken into account it behaves like 46 equally weighted holdings.
What is PSCH's expense ratio? 0.29% a year
As of October 9, 2026, PSCH charges 0.29% a year and holds $173M in assets across 69 positions.
| Measure | PSCH |
|---|---|
| Expense ratio | 0.29% |
| Assets under management | $173M |
| Holdings | 69 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Invesco S&P SmallCap Health Care ETF (PSCH) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/psch
ETF Copilot Pro unlocks PSCH's price and what each holding weighs.
Try Pro free →